Privia Health Group, Inc. Financials

Privia Health Group, Inc. (PRVA) reported $1.7B in total revenue for fiscal year 2024. This represents a 4.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Privia Health Group, Inc. (PRVA) revenue grew by 4.7% year-over-year, from $1.7B to $1.7B in fiscal year 2024.

Yes, Privia Health Group, Inc. (PRVA) reported a net income of $14.4M in fiscal year 2024, with a net profit margin of 0.8%.

Privia Health Group, Inc. (PRVA) reported diluted earnings per share of $0.11 for fiscal year 2024. This represents a -42.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Privia Health Group, Inc. (PRVA) had EBITDA of $24.3M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

Privia Health Group, Inc. (PRVA) had an operating margin of 1.0% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

Privia Health Group, Inc. (PRVA) had a net profit margin of 0.8% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Privia Health Group, Inc. (PRVA) has a return on equity of 2.3% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

Privia Health Group, Inc. (PRVA) generated $109.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

Privia Health Group, Inc. (PRVA) had $1.1B in total assets as of fiscal year 2024, including both current and long-term assets.

Privia Health Group, Inc. (PRVA) had 120M shares outstanding as of fiscal year 2024.

Privia Health Group, Inc. (PRVA) had a current ratio of 1.86 as of fiscal year 2024, which is generally considered healthy.

Privia Health Group, Inc. (PRVA) had a debt-to-equity ratio of 0.71 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

Privia Health Group, Inc. (PRVA) had a return on assets of 1.3% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

Privia Health Group, Inc. (PRVA) has an Altman Z-Score of 5.27, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress.

Privia Health Group, Inc. (PRVA) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals.

Privia Health Group, Inc. (PRVA) has an earnings quality ratio of 7.60x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation.

Privia Health Group, Inc. (PRVA) scores 39 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks.